RxDoctor Payments Data

Alexander Moses, PA

Physician Assistant · Kalispell, MTNPI 1649893637

Payments from drug & device makers

$1,177in general payments, 2019–2025

Across 62 payments — averaging $18.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$479
  • Boehringer Ingelheim$173
  • Neurocrine Biosciences, Inc.$110
  • Vanda Pharmaceuticals Inc.$77
  • AstraZeneca$60
  • Otsuka America Pharmaceutical, Inc.$58
  • plus $218 from 8 others

What the payments were for

  • Food & beverage$1,177100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,177 in reported general payments places this provider in the 85th percentile of 626 physician assistant providers in Montana.

See all physician assistant providers in Montana

Medicare billing

Part B allowed, 2024
$1,159
Medicare patients
36
Services billed
67

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BiktarvyBictegrav/Emtricit/Tenofov Ala11$38,421
TrulicityDulaglutide26$31,156
FarxigaDapagliflozin Propanediol27$30,055
EliquisApixaban31$21,138
XareltoRivaroxaban27$18,953
OzempicSemaglutide18$16,069
JardianceEmpagliflozin27$15,384
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog11$13,432
LinzessLinaclotide16$8,042
Repatha SureclickEvolocumab11$6,201
Advair HfaFluticasone Propion/Salmeterol14$5,049
Lantus SolostarInsulin Glargine,hum.Rec.Anlog21$3,108
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl16$3,100
Novolog FlexpenInsulin Aspart15$2,641
Fluticasone-SalmeterolFluticasone Propion/Salmeterol14$2,257

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$33$31,15626 claims
AstraZenecaFarxiga$60$30,05527 claims
Novo NordiskOzempic$14$16,06918 claims
Boehringer IngelheimJardiance$173$15,38427 claims
AbbVieLinzess$479$8,04216 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 626 physician assistant providers in Montana.

Other physician assistant in Kalispell

See the full list for Montana

Where these figures come from

Is this you, or does something look wrong? →